Skip to main content

ImmunityBio, Inc. (NASDAQ: IBRX) Investor Securities Class Action Lawsuit 06/30/2023

  • If you purchased a significant amount of shares of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, and / or if you purchased any NASDAQ: IBRX shares prior to May 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: August 29, 2023. NASDAQ: IBRX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 17, 2023 - An amended complaint was filed. June 30, 2023 - An investor in shares of ImmunityBio, Inc. (NASDAQ: IBRX) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by ImmunityBio, Inc. in connection with certain allegedly false and misleading statements made between May 23, 2022 and May 10,...

You must register (for free) or login to view the entire case.